Sign inGet started

Ayer Capital Management, LP

Insider CIK 1471149 · GNBP Director, 10% owner · ACCP 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
LBIO Lion Biotechnologies, Inc. S Sale2015-05-012015-05-082,780,682$9.62 $26.75M2,823,333SEC↗
GNBP Lion Biotechnologies, Inc. C Conversion deriv2013-05-222014-07-231— $00SEC↗
GNBP Lion Biotechnologies, Inc. C Conversion deriv2013-05-222014-07-231— $00SEC↗
GNBP Lion Biotechnologies, Inc. C Conversion deriv2013-05-222014-07-231$1.25 $10SEC↗
GNBP Lion Biotechnologies, Inc. C Conversion deriv2013-05-222014-07-231$1.25 $10SEC↗
GNBP Lion Biotechnologies, Inc. J Other2013-05-222014-07-23560,088,650$0.05 $28.00M560,401,150SEC↗
ACCP ACCESS PHARMACEUTICALS INC S Sale2012-06-292012-06-29179,157$0.55 $98.5K2,413,163SEC↗
ACCP ACCESS PHARMACEUTICALS INC S Sale2012-06-282012-06-2925,000$0.68 $17.0K2,592,320SEC↗
ACCP ACCESS PHARMACEUTICALS INC S Sale2012-05-162012-05-16140,300$0.67 $94.0K2,617,320SEC↗
ACCP ACCESS PHARMACEUTICALS INC S Sale2012-05-152012-05-161,000$0.85 $8502,757,620SEC↗